Quarterly Activities Report for September 2022

October 25, 2022

https://www.globenewswire.com/news-release/2022/10/25/2540575/0/en/Quarterly-Activities-Report-for-September-2022.html

ADELAIDE, Australia, Oct. 25, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (ASX:BNO, Nasdaq:BNOX), (Bionomics or the Company) a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (“CNS”) disorders with high unmet medical need, today released its Appendix 4C – Quarterly Cashflow Report. Highlights during the Quarter ended 30 September 2022 (Quarter) and up to the date of this announcement include:

Read more at globenewswire.com

Related news for (BNOX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.